TLR2 on CD4+ and CD8+ T cells promotes control of Mycobacterium tuberculosis infection

Scott M. Reba,Qing Li,Sophia Onwuzulike,Nancy Nagy,Shane Fletcher,Kyle Parker,Rachel J Shaw,Katharine Umphred‐Wilson,Supriya Shukla,Clifford V. Harding,W. Henry Boom,Roxana E. Rojas
DOI: https://doi.org/10.1002/eji.202350715
2024-03-08
European Journal of Immunology
Abstract:Co‐stimulation of activated T cells through their upregulated TLR2 by Mycobacterium tuberculosis pathogen‐associated molecular patterns enhances mycobacterial control in vivo. Although a role for TLR2 on T cells has been indicated in prior studies, in vivo stimulation of TLR2 on T cells by Mtb and its impact on Mtb infection has not been tested. Furthermore, it is not known if the enhanced susceptibility to Mtb of Tlr2 gene knockout mice is due to its role in macrophages, T cells, or both. To address TLR2 on T cells, we generated Tlr2fl/flxCd4cre/cre mice, which lack expression of TLR2 on both CD4 and CD8 T cells, to study the in vivo role of TLR2 on T cells after aerosol infection with virulent Mtb. Deletion of TLR2 in CD4+ and CD8+ T cells reduces their ability to be co‐stimulated by TLR2 ligands for cytokine production. These include both pro‐ (IFN‐γ, TNF‐α) and anti‐inflammatory cytokines (IL‐10). Deletion of TLR2 in T cells affected control of Mtb in the lungs and spleens of infected mice. This suggests that T‐cell co‐stimulation by mycobacterial TLR2 ligands in vivo contributes to the control of Mtb infection in the lung and spleen.
immunology
What problem does this paper attempt to address?